SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Jun-24 5:00 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 04-Jun-24 | Option Exercise | 40,000 | $4.01 | $160,400.00 | 19% 212.15K to 252.15K | |
05-Jun-24 5:00 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 04-Jun-24 | Option Sale | 17,323 | $15.98 | $276,735.00 | (7%) 252.15K to 234.82K | |
16-Feb-24 5:01 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 1,186 | -- | -- | (< 1%) 213.33K to 212.15K | |
16-Feb-24 5:01 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | 2% 209.33K to 213.33K | |
29-Dec-23 5:00 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 1,333 | -- | -- | < 1% 208.0K to 209.33K | |
11-Dec-23 5:00 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 07-Dec-23 | Option Exercise | 60,000 | $1.13 | $67,800.00 | 41% 148.0K to 208.0K | |
16-May-23 5:01 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 12-May-23 | Option Exercise | 50,000 | $0.79 | $39,500.00 | 51% 98.0K to 148.0K | |
03-Mar-23 9:20 AM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 02-Mar-23 | Disposition | 7,800 | $20.00 | $156,000.00 | (100%) 7.8K to 0 | |
17-Feb-23 5:00 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-23 | Option Exercise | 4,000 | -- | -- | 4% 94.0K to 98.0K | |
08-Dec-22 5:01 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 06-Dec-22 | Option Exercise | 1,334 | -- | -- | 1% 92.67K to 94.0K | |
26-Aug-22 5:01 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 24-Aug-22 | Option Exercise | 40,000 | $2.53 | $101,200.00 | 76% 52.67K to 92.67K | |
14-Jun-22 4:58 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 14-Jun-22 | Grant | 2,000 | -- | -- | 34% 5.8K to 7.8K | |
26-Jan-22 5:29 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 25-Jan-22 | Option Exercise | 50,000 | $3.35 | $167,500.00 | 1875% 2.67K to 52.67K | |
06-Dec-21 5:10 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 03-Dec-21 | Option Exercise | 1,333 | -- | -- | 100% 1.33K to 2.67K | |
16-Jun-21 4:07 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 15-Jun-21 | Grant | 2,000 | -- | -- | 53% 3.8K to 5.8K | |
28-Dec-20 4:35 PM View: | Catalyst Pharmaceutical Par... (CPRX) | 22-Dec-20 | Option Exercise | 1,333 | -- | -- | 100% 0 to 1.33K | |
15-Jun-20 4:16 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 15-Jun-20 | Grant | 2,000 | -- | -- | 111% 1.8K to 3.8K | |
02-Mar-20 4:04 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 12-Sep-19 | Market Purchase | 1,800 | $13.90 | $25,020.00 | 100% 0 to 1.8K | (8%) |
18-May-17 1:02 PM View: | Neuralstem Inc. (PALI) | 17-May-17 | Market Purchase | 7,500 | $4.00 | $30,000.00 | 47% 15.81K to 23.31K | (99%) |
27-Feb-17 4:30 PM View: | Neuralstem Inc. (PALI) | 24-Feb-17 | Market Purchase | 2,591 | $3.86 | $10,001.30 | 20% 13.22K to 15.81K | (99%) |
27-Jan-17 4:18 PM View: | Neuralstem Inc. (PALI) | 25-Jan-17 | Market Purchase | 2,841 | $3.52 | $10,000.30 | 27% 10.38K to 13.22K | (99%) |
30-Dec-16 4:05 PM View: | Neuralstem Inc. (PALI) | 23-Dec-16 | Market Purchase | 32,259 | $0.31 | $10,000.30 | 31% 102.68K to 134.94K | (99%) |
28-Nov-16 5:36 PM View: | Neuralstem Inc. (PALI) | 25-Nov-16 | Market Purchase | 35,715 | $0.28 | $10,000.20 | 53% 66.97K to 102.68K | (99%) |
27-Oct-16 4:05 PM View: | Neuralstem Inc. (PALI) | 25-Oct-16 | Market Purchase | 35,715 | $0.28 | $10,000.20 | 114% 31.25K to 66.97K | (99%) |
26-Sep-16 4:50 PM View: | Neuralstem Inc. (PALI) | 23-Sep-16 | Market Purchase | 31,250 | $0.32 | $10,000.00 | 100% 0 to 31.25K | (99%) |